Search research articles
Contact Us
Filters
Showing results (871-880 of 1,171) with videos related to
Page
of 118
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Nature Communications
|
March 14, 2023
Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
Jeffrey Patterson-Fortin, Heta Jadhav, Constantia Pantelidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors
Gregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 6, 2021
Crizotinib in Patients With MET-Amplified NSCLC
D Ross Camidge, Gregory A Otterson, Jeffrey W Clark, et al.
International Immunology
|
October 7, 2004
The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge
Janine L Ferrant, Christopher D Benjamin, Anne H Cutler, et al.
ESMO Open
|
September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
H Park, G I Shapiro, X Gao, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
October 30, 2015
Prediction of microcephaly at birth using three reference ranges for fetal head circumference: can we improve prenatal diagnosis?
Z Leibovitz, E Daniel-Spiegel, G Malinger, et al.
Investigational New Drugs
|
September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Suzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial
Katherine R Tuttle, Lance D Dworkin, William Henrich, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 6, 2024
Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness
Rombout B E van Amstel, Brian Bartek, Alexander P J Vlaar, et al.
Page
of 118
Search research articles
Search
Showing results (871-880 of 1,171) with videos related to
Sort By:
Page
of 118
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Nature Communications
|
March 14, 2023
Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
Jeffrey Patterson-Fortin, Heta Jadhav, Constantia Pantelidou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors
Gregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 6, 2021
Crizotinib in Patients With MET-Amplified NSCLC
D Ross Camidge, Gregory A Otterson, Jeffrey W Clark, et al.
International Immunology
|
October 7, 2004
The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge
Janine L Ferrant, Christopher D Benjamin, Anne H Cutler, et al.
ESMO Open
|
September 9, 2022
Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
H Park, G I Shapiro, X Gao, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
October 30, 2015
Prediction of microcephaly at birth using three reference ranges for fetal head circumference: can we improve prenatal diagnosis?
Z Leibovitz, E Daniel-Spiegel, G Malinger, et al.
Investigational New Drugs
|
September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Suzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
May 27, 2016
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial
Katherine R Tuttle, Lance D Dworkin, William Henrich, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 6, 2024
Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness
Rombout B E van Amstel, Brian Bartek, Alexander P J Vlaar, et al.
Page
of 118